Trial no.:
|
PACTR202110667430356 |
Date of Approval:
|
08/10/2021 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Milligan Morgan hemorrhoidectomy under local anesthesia versus saddle block: A randomized controlled trial |
Official scientific title |
Open hemorrhoidectomy under local anesthesia versus saddle block at Kampala International University Teaching Hospital: A randomized controlled trial |
Brief summary describing the background
and objectives of the trial
|
Hemorrhoids, the most prevalent anal disease, is defined as collections of submucosal, fibrovascular, arterio-venous sinusoids that are part of the anorectum. Many surgeons currently use various management options to treat hemorrhoids. These options range from conservative treatment including dietary measures and sclerotherapy to surgical techniques include band ligation and excision based on the degree of prolapse and the classification by Banov and colleagues, grade III and IV hemorrhoids are amenable to surgical treatment and open hemorrhoidectomy seems to be the most common technique widely effective for grade III and IV hemorrhoids. While open hemorrhoidectomy under local anesthesia is well applied in developed countries, it is not the case in low-income countries like Uganda, which would actually benefit most from this technique. Purpose of the study This study aims to compare open hemorrhoidectomy using local anesthesia versus saddle block among patients with primary uncomplicated 3rd or 4th-degree hemorrhoids at KIU-TH in Uganda. Specific objectives i. To assess the occurrence of postoperative pain following open hemorrhoidectomy under local anesthesia versus open hemorrhoidectomy under saddle block; ii. To compare the mean operative time for open hemorrhoidectomy under local anesthesia versus open hemorrhoidectomy under saddle block; iii. To compare the cost-effectiveness between open hemorrhoidectomy under local anesthesia and Saddle block. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Digestive System |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
03/11/2021 |
Actual trial start date |
|
Anticipated date of last follow up |
28/02/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
58 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|